343 related articles for article (PubMed ID: 31940619)
21. Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors.
Sartim AG; Guimarães FS; Joca SR
Behav Brain Res; 2016 Apr; 303():218-27. PubMed ID: 26801828
[TBL] [Abstract][Full Text] [Related]
22. Activation and blockade of serotonin
Liu KC; Li JY; Xie W; Li LB; Zhang J; Du CX; Zhang YM; Tan HH; Wang HS; Zhang L
Brain Res; 2016 Nov; 1650():184-195. PubMed ID: 27616337
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
van Amsterdam C; Seyfried CA
Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
[TBL] [Abstract][Full Text] [Related]
24. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders.
Winstanley CA; Theobald DE; Dalley JW; Robbins TW
Neuropsychopharmacology; 2005 Apr; 30(4):669-82. PubMed ID: 15688093
[TBL] [Abstract][Full Text] [Related]
25. 8-OH-DPAT-induced release of hippocampal noradrenaline in vivo: evidence for a role of both 5-HT1A and dopamine D1 receptors.
Hajós-Korcsok E; Sharp T
Eur J Pharmacol; 1996 Oct; 314(3):285-91. PubMed ID: 8957248
[TBL] [Abstract][Full Text] [Related]
26. Activation and blockade of serotonin
Guo Y; Zhang L; Zhang J; Du CX; Lv SX; Wang T; Wang HS; Xie W; Liu J
Neurol Res; 2019 Jul; 41(7):585-593. PubMed ID: 30929589
[No Abstract] [Full Text] [Related]
27. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
[TBL] [Abstract][Full Text] [Related]
28. Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease.
Lindenbach D; Dupre KB; Eskow Jaunarajs KL; Ostock CY; Goldenberg AA; Bishop C
Brain Res; 2013 Nov; 1537():327-39. PubMed ID: 24060645
[TBL] [Abstract][Full Text] [Related]
29. Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.
Dupre KB; Eskow KL; Barnum CJ; Bishop C
Neuropharmacology; 2008 Dec; 55(8):1321-8. PubMed ID: 18824001
[TBL] [Abstract][Full Text] [Related]
30. [Effect of 8-OH-DPAT on the depressive behavior and monoamine metabolism in the hippocampus of ovariectomized rats].
Fedotova IuO
Eksp Klin Farmakol; 2006; 69(1):12-7. PubMed ID: 16579052
[TBL] [Abstract][Full Text] [Related]
31. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis.
Nakai K; Fujii T; Fujimoto K; Suzuki T; Kawashima K
Neurosci Res; 1998 May; 31(1):23-9. PubMed ID: 9704975
[TBL] [Abstract][Full Text] [Related]
32. 5-HT1A receptors in the dorsal hippocampus mediate the anxiogenic effect induced by the stimulation of 5-HT neurons in the median raphe nucleus.
Dos Santos L; de Andrade TG; Zangrossi Junior H
Eur Neuropsychopharmacol; 2008 Apr; 18(4):286-94. PubMed ID: 17728111
[TBL] [Abstract][Full Text] [Related]
33. Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson's disease.
Mignon L; Wolf WA
Psychopharmacology (Berl); 2007 May; 192(1):49-59. PubMed ID: 17265149
[TBL] [Abstract][Full Text] [Related]
34. Role of serotonin 1A receptors in the median raphe nucleus on the behavioral consequences of forced swim stress.
Almeida PV; Trovo MC; Tokumoto AM; Pereira AC; Padovan CM
J Psychopharmacol; 2013 Dec; 27(12):1134-40. PubMed ID: 24162801
[TBL] [Abstract][Full Text] [Related]
35. R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex.
Kuroki T; Ichikawa J; Dai J; Meltzer HY
Brain Res; 1996 Dec; 743(1-2):357-61. PubMed ID: 9017269
[TBL] [Abstract][Full Text] [Related]
36. In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat.
Lladó-Pelfort L; Assié MB; Newman-Tancredi A; Artigas F; Celada P
Psychopharmacology (Berl); 2012 May; 221(2):261-72. PubMed ID: 22147258
[TBL] [Abstract][Full Text] [Related]
37. Investigation of mechanisms mediating 8-OH-DPAT-induced impairment of spatial memory: involvement of 5-HT1A receptors in the dorsal hippocampus in rats.
Egashira N; Yano A; Ishigami N; Mishima K; Iwasaki K; Fujioka M; Matsushita M; Nishimura R; Fujiwara M
Brain Res; 2006 Jan; 1069(1):54-62. PubMed ID: 16386718
[TBL] [Abstract][Full Text] [Related]
38. Differential regional antagonism of 8-OH-DPAT-induced decrease in serotonin synthesis by two 5-HT1A receptor antagonists.
Larsson LG; Stenfors C; Ross SB
Eur J Pharmacol; 1998 Apr; 346(2-3):209-15. PubMed ID: 9652362
[TBL] [Abstract][Full Text] [Related]
39. Prelimbic α
Wu ZH; Zhang QJ; Du CX; Xi Y; Li WJ; Guo FY; Yu SQ; Yang YX; Liu J
Brain Res Bull; 2017 Sep; 134():99-108. PubMed ID: 28716399
[TBL] [Abstract][Full Text] [Related]
40. Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain.
Assié MB; Ravailhe V; Faucillon V; Newman-Tancredi A
J Pharmacol Exp Ther; 2005 Oct; 315(1):265-72. PubMed ID: 15987834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
